Key result
Special Intervention reduced CVD mortality for highly adherent men (RR 0.91; 95% CI 0.84-0.99) but increased it for poorly adherent men (RR 1.28; 95% CI 1.05-1.57) compared to Usual Care.
Why the study?
Does Special Intervention reduce cardiovascular disease mortality in men compared to Usual Care, and how does adherence modify this effect?
Population
12,338 men in the Multiple Risk Factor Intervention Trial (MRFIT)
Comparison
Special Intervention (SI) vs Usual Care (UC)
Design
RCT, Randomization to Special Intervention (SI) or Usual Care (UC)
Follow-up
9 years
Authors
Loading...
Adherence modifies multiple risk factor intervention effects on CVD mortality; challenges uniform application and extends trials by identifying harm in poorly adherent men.
RCT (n=12,338)
Randomized
Does Special Intervention reduce cardiovascular disease mortality in men compared to Usual Care, and how does adherence modify this effect?
Relative Risk: 0.91 (95% CI 0.84–0.99)
p-value: p=0.002 for interaction
The efficacy of a multiple risk factor intervention on CVD mortality is highly dependent on patient adherence, with benefits seen in highly adherent patients and potential harm in poorly adherent patients.
Gump et al. (2003) conducted an RCT in Cardiovascular disease (n=12,338). Special Intervention (SI) vs. Usual Care (UC) was evaluated on Cardiovascular disease (CVD) mortality for highly adherent participants (RR 0.91, 95% CI 0.84-0.99, p=0.002 for interaction). Special Intervention reduced CVD mortality for highly adherent men (RR 0.91; 95% CI 0.84-0.99) but increased it for poorly adherent men (RR 1.28; 95% CI 1.05-1.57) compared to Usual Care.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: